National Cancer Institute: Special Category: NIH Clinical Center trial is conducting a Phase I trial:
Gemcitabine combined with Mistletoe in treating patients with advanced Solid Tumor.
Trial Lead Organization:
National Center for Complementary and Alternative Medicine
e-mail: manskyp@mail.nih.gov
Trial Site:
Maryland, Bethesda
Warren Grant Magnuson Clinical Center
Patient Recruitment: Ph. 800-411-1222
Criteria include the following:
No CNS matastases
No previous mistletoe or gemcitabine